Prognostic significance and immune correlates of CD73 expression in renal cell carcinoma
Abhishek Tripathi(ITM University), Lauren C. Harshman(Dana-Farber Cancer Institute)
Cited by 36
Related Papers
Change in neutrophil-to-lymphocyte ratio (NLR) in response to immune checkpoint blockade for metastatic renal cell carcinoma
|Journal for ImmunoTherapy of Cancer|2018|267
Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma
|Nature Communications|2021|167
Results of a Multicenter Phase II Study of Atezolizumab and Bevacizumab for Patients With Metastatic Renal Cell Carcinoma With Variant Histology and/or Sarcomatoid Features
|Journal of Clinical Oncology|2019|147
Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma
|New England Journal of Medicine|2024|145
The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non–Clear Cell Renal Cell Carcinoma
|Cancer Immunology Research|2018|136